It is well-known that enhanced IP3K/Akt signaling plays a key role in the development of the epileptogenesis and ictogenesis of various epileptic syndromes via suppression of the tuberous sclerosis complex (TSC) and activation of mammalian target of rapamycin (mTOR) signaling [47]. The gene discussed is AKT1; the disease is epilepsy syndrome.